Literature DB >> 28330961

Reference values for developing responsive functional outcome measures across the lifespan.

Marnee J McKay1, Jennifer N Baldwin2, Paulo Ferreira2, Milena Simic2, Natalie Vanicek2, Joshua Burns2.   

Abstract

OBJECTIVE: To generate a reference dataset of commonly performed functional outcome measures in 1,000 children and adults and investigate the influence of demographic, anthropometric, strength, and flexibility characteristics.
METHODS: Twelve functional outcome measures were collected from 1,000 healthy individuals aged 3-101 years: 6-minute walk test, 30-second chair stand test, timed stairs test, long jump, vertical jump, choice stepping reaction time, balance (Star Excursion Balance Test, tandem stance eyes open and closed, single-leg stance eyes closed), and dexterity (9-hole peg test, Functional Dexterity Test). Correlation and multiple regression analyses were performed to identify factors independently associated with each measure.
RESULTS: Age- and sex-stratified reference values for functional outcome measures were generated. Functional performance increased through childhood and adolescence, plateaued during adulthood, and declined in older adulthood. While balance did not differ between the sexes, male participants generally performed better at gross motor tasks while female participants performed better at dexterous tasks. Height was the most consistent correlate of functional performance in children, while lower limb muscle strength was a major determinant in adolescents and adults. In older adults, age, lower limb strength, and joint flexibility explained up to 63% of the variance in functional measures.
CONCLUSIONS: These normative reference values provide a framework to accurately track functional decline associated with neuromuscular disorders and assist development and validation of responsive outcome measures for therapeutic trials.
© 2017 American Academy of Neurology.

Entities:  

Mesh:

Year:  2017        PMID: 28330961     DOI: 10.1212/WNL.0000000000003847

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

1.  12-Month progression of motor and functional outcomes in congenital myotonic dystrophy.

Authors:  Kellen H Quigg; Kiera N Berggren; Melissa McIntyre; Kameron Bates; Francesca Salmin; Jacopo L Casiraghi; Adele DʼAmico; Guja Astrea; Federica Ricci; Marnee J McKay; Jennifer N Baldwin; Joshua Burns; Craig Campbell; Valeria A Sansone; Nicholas E Johnson
Journal:  Muscle Nerve       Date:  2021-01-10       Impact factor: 3.217

2.  An exploratory natural history of ataxia of Charlevoix-Saguenay: A 2-year follow-up.

Authors:  Cynthia Gagnon; Isabelle Lessard; Caroline Lavoie; Isabelle Côté; Raphaël St-Gelais; Jean Mathieu; Bernard Brais
Journal:  Neurology       Date:  2018-08-29       Impact factor: 9.910

3.  Sex- and Age-Specific Centile Curves and Downloadable Calculator for Clinical Muscle Strength Tests to Identify Probable Sarcopenia.

Authors:  Stuart J Warden; Ziyue Liu; Sharon M Moe
Journal:  Phys Ther       Date:  2022-03-01

4.  A multinational study on motor function in early-onset FSHD.

Authors:  Jean K Mah; Jia Feng; Marni B Jacobs; Tina Duong; Kate Carroll; Katy de Valle; Cara L Carty; Lauren P Morgenroth; Michela Guglieri; Monique M Ryan; Paula R Clemens; Mathula Thangarajh; Richard Webster; Edward Smith; Anne M Connolly; Craig M McDonald; Peter Karachunski; Mar Tulinius; Amy Harper; Avital Cnaan; Yi-Wen Chen
Journal:  Neurology       Date:  2018-03-14       Impact factor: 9.910

5.  DNA damage and neurodegenerative phenotypes in aged Ciz1 null mice.

Authors:  Mohammad Moshahid Khan; Jianfeng Xiao; Damini Patel; Mark S LeDoux
Journal:  Neurobiol Aging       Date:  2018-02       Impact factor: 4.673

6.  Translation and cross-cultural adaptation of the Charcot-Marie-Tooth disease Pediatric Scale to Brazilian Portuguese and determination of its measurement properties.

Authors:  Karoliny Lisandra Teixeira Cruz; Ana Cristina Resende Camargos; Juliana Cardoso; Cyntia Rogean de Jesus Alves de Baptista; Aline Duprat Ramos; Ana Claudia Mattiello-Sverzut; Joshua Burns; Hércules Ribeiro Leite
Journal:  Braz J Phys Ther       Date:  2020-08-07       Impact factor: 3.377

7.  Limitations of 6-minute walk test reference values for spinal muscular atrophy.

Authors:  Ashley M Goodwin; Kayla M D Cornett; Marnee J McKay; Joshua Burns; Carol Ewing Garber; Darryl C De Vivo; Jacqueline Montes
Journal:  Muscle Nerve       Date:  2020-01-16       Impact factor: 3.217

8.  Reliability of the Charcot-Marie-Tooth functional outcome measure.

Authors:  Paula Bray; Kayla M D Cornett; Timothy Estilow; Davide Pareyson; Riccardo Zuccarino; Mariola Skorupinska; Menelaos Pipis; Janet E Sowden; Steven Scherer; Mary M Reilly; Michael E Shy; David N Herrmann; Joshua Burns; Katy J Eichinger
Journal:  J Peripher Nerv Syst       Date:  2020-08-26       Impact factor: 3.494

9.  Patient-specific reference values for objective physical function tests: data from the Osteoarthritis Initiative.

Authors:  Matthew S Harkey; Lori Lyn Price; Kieran F Reid; Grace H Lo; Shao-Hsien Liu; Kate L Lapane; Lucas Ogura Dantas; Timothy E McAlindon; Jeffrey B Driban
Journal:  Clin Rheumatol       Date:  2020-02-06       Impact factor: 2.980

10.  The Charcot-Marie-Tooth Functional Outcome Measure (CMT-FOM).

Authors:  Katy Eichinger; Joshua Burns; Kayla Cornett; Chelsea Bacon; Mary Lohse Shepherd; Joan Mountain; Janet Sowden; Rosemary Shy; Michael E Shy; David N Herrmann
Journal:  Neurology       Date:  2018-09-19       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.